Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesmary Modugno

Showing results (91-100 of 203) with videos related to

Pageof 21
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
Cancers|April 23, 2022
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter AnalysisChristoph Wohlmuth, Vladimir Djedovic, Susanne K Kjaer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell CarcinomaJulie M Cunningham, Stacey J Winham, Chen Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Pageof 21

Showing results (91-100 of 203) with videos related to

Sort By:
Pageof 21
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2022
Reproductive Factors Do Not Influence Survival with Ovarian CancerMinh Tung Phung, Aliya Alimujiang, Andrew Berchuck, et al.
Cancers|April 23, 2022
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter AnalysisChristoph Wohlmuth, Vladimir Djedovic, Susanne K Kjaer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2013
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortiumMartin Köbel, Steve E Kalloger, Sandra Lee, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell CarcinomaJulie M Cunningham, Stacey J Winham, Chen Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Pageof 21